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There are several human serum proteins for which no clear role is yet known. Among these is the
abundant serum protein beta2-glycoprotein-I (b2GPI), which is known to bind to negatively charged
phospholipids as well as to bacterial lipopolysaccharides (LPS), and was therefore proposed to play a
role in the immune response. To understand the details of these interactions, a biophysical analysis
of the binding of b2GPI to LPS and phosphatidylserine (PS) was performed. The data indicate only a
moderate tendency of the protein (1) to inﬂuence the LPS-induced cytokine production in vitro, (2)
to react exothermally with LPS in a non-saturable way, and (3) to change its local microenvironment
upon LPS association. Additionally, we found that the protein binds more strongly to phosphatidyl-
serine (PS) than to LPS. Furthermore, b2GPI converts the LPS bilayer aggregates into a stronger mul-
tilamellar form, and reduces the ﬂuidity of the hydrocarbon moiety of LPS due to a rigidiﬁcation of
the acyl chains. From these data it can be concluded that b2GPI plays a role as an immune-modulat-
ing agent, but there is much less evidence for a role in immune defense against bacterial toxins such
as LPS.
 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Serum proteins such as albumin or low- and high-density lipo-
proteins (LDL and HDL) fulﬁll a variety of physiological tasks like
transport, adhesion, recognition and defenses against invading
microorganisms. To this class also belong lipopolysaccharide-
binding protein (LBP) and lactoferrin which are considerably
up-regulated in acute phase serum i.e. in the case of bacterial infec-
tions [1,2]. In contrast the function of the abundant serum protein
b2GPI is not completely understood. Various publications pre-
sented data on its role as binding molecule to acidic lipids. Actuallythe analysis of the crystal structure of b2GPI [3,4] gave evidence for
domain V being an excellent counterpart for negatively charged
phospholipids. These data were extended by Hammel et al. [5]
who found a direct interaction of acidic phospholipids such as car-
diolipin with the hydrophobic loop adjacent to the positively
charged lysine-rich region of domain V of b2GPI.
There is some evidence that b2GPI may also play a role as regu-
lator of the immune response to bacterial toxins such as lipopoly-
saccharide (LPS, endotoxin). Laplante and co-workers published
data giving evidence that b2GPI interacts speciﬁcally with LPS
and that both LPS and Toll-like receptor 4 (TLR4) are required for
b2GPI to activate macrophages [6]. This idea was even more
expressed in the investigations of Agar et al. [7] who proposed that
b2GPI might be a scavenger of LPS deduced from the inhibition of
the LPS-induced expression of tissue factor and interleukin-6
(IL-6) from monocytes.
From these ﬁndings the role of b2GPI still does not seem to be
clear. Therefore, we have applied various biophysical techniques
to study the interaction of b2GPI with LPS in more detail. This is
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the immune system known in nature. It is responsible, for example,
for the induction of many cytokines and chemokines but also for
the production of prostaglandins in human mononuclear cells
[8]. These induction mechanisms may be beneﬁcial at low amounts
of LPS but lead to pathophysiological reactions at higher LPS con-
centrations such as the induction of sepsis. Although b2GPI binds
to LPS we did not get evidence for a signiﬁcant role of b2GPI as
defense protein. We propose rather an activity-modulating role
possibly in the sense of an immune modulation which may be
important to combat LPS-induced inﬂammation by enhancing the
innate immunity.
2. Materials and methods
2.1. Lipopolysaccharide and b2GPI
Lipopolysaccharides from Salmonella enterica Minnesota rough
mutants Re and Ra, strains R595 and R60 were extracted from
the bacteria grown at 37 C by the phenol:chloroform:petrol ether
(PCP) method, puriﬁed and used in the natural salt form [9]. The
purity was examined by MALDI-TOF mass spectrometry and LPS
samples were only used when the chemical structure in particular
of the lipid A part consisted of a diglucosamine to which six acyl
chains in amide- and ester-linkage at positions 2 and 20, and 3
and 30, respectively, were bound and which were phosphorylated
at positions 1 and 40, according to the known structure of lipid A.
LPS Re and Ra were either dissolved in 50 mM Tris–HCl, 25 mM
NaCl, 0.1 g/L EDTA, pH 7.4 (Tris–HCl) or in 20 mM Hepes buffer at
concentrations of 1 mg/ml. The samples were sonicated for 20 min
at 60 C followed by 30 min cooling to 4 C and afterwards
reheated to 60 C for 30 min and ﬁnally stored at 4 C for at least
12 h before use.
2.2. Phospholipids
Egg yolk phosphatidylcholine (Egg-PC) or phospatidylserine
(PS) purchased from Avanti Polar Lipids (Alabaster, USA) were dis-
solved in chloroform/methanol 2:1 (v/v). The organic solvents
were evaporated at 40 C under a stream of nitrogen. The ﬁlm
was dried in high vacuum overnight to remove residual traces of
solvent. The dry lipid ﬁlm (1 mg lipid) was suspended in 1 ml
Tris–HCl and hydrated at 50 C for 1 h interrupted by vigorous
mixing every 10 min. Lipid suspensions were extruded through a
polycarbonate ﬁlter with 100 nm pore size using a LiposoFast
pneumatic extruder (Avestin, Inc. Ottawa, ON).
2.3. Isolation of beta2-glycoprotein-I
b2GPI was puriﬁed from human plasma by treatment with 1.4%
(v/v) perchloric acid followed by afﬁnity chromatography on hep-
arin–sepharose and cation exchange chromatography on Mono S
(Pharmacia, Sweden) [10]. The preparation was homogenous as
judged by SDS/PAGE (10% resolving and 3.75% stacking gel) yield-
ing a single band.
2.4. Intrinsic Trp-ﬂuorescence
Trp-ﬂuorescence was recorded on a Spex Fluoromax-3 ﬂuores-
cence spectrometer (Jobin Yvon Horiba, Longjumeau, France) using
a 10 mm  10 mm quartz cuvette. Trp-residues were excited at
292 nm and emission spectra were recorded from 320 to 380 nm
with an increment of 1 nm. Band widths of 5 nm were used for
excitation and emission with an integration time of 0.1 s, averaging
10 scans. The emission scans were processed for inner ﬁlter andinstrumental corrections and the background intensities of the
samples without protein were subtracted. Titration experiments
were performed with continuous stirring by adding aliquots of
LPS (0.5 mg/ml suspended in Tris–HCl) into the cuvette containing
b2GPI (50 lg/ml, 1.1 lM) dissolved in the same buffer. The ratio of
LPS/b2GPI was incrementally increased from 0 to 40 mol/mol by
titration. Control experiments were performed in the same way
by adding aliquots of Egg-PC unilamellar vesicles.
The temperature of the cuvette was maintained at 25 C and the
single measurements were taken after 10 min of equilibration.
2.5. Acrylamide quenching of Trp ﬂuorescence
Aliquots of a 3 M acrylamide stock solution in Tris–HCl were
added to a 1.1 lM solution of b2GPI containing 20 mol LPS/mol
protein. The acrylamide concentration was varied in a range
between 0.02 and 0.45 M. The experimental conditions were as
described above. The values obtained were corrected for volume
increase and scattering derived from acrylamide titration of LPS.
The ﬂuorescence quenching data were analyzed with a Stern–
Volmer plot. In the case where both static and dynamic quenching
occur simultaneously in the sample the following modiﬁed form of
the Stern–Volmer equation holds
I0=I ¼ ð1þ KSV½Q ÞexpV ½Q 
where I0 is the ﬂuorescence intensity at zero quencher concentra-
tion, I is the maximum intensity at a given quencher concentration
[Q], and Ksv is the Stern–Volmer quenching constant. The term
exp(V[Q]) is used as a phenomenological descriptor of the quench-
ing process where V represents an active volume of a sphere around
the ﬂuorophore to such an extent that any quencher within this
volume is able to quench the excited ﬂuorophore at the time of ﬂuo-
rophore excitation.
2.6. Stimulation of human mononuclear cells by LPS
The stimulation of human mononuclear cells (MNC) was per-
formed as described previously [11]. Brieﬂy MNC were isolated
from heparinized blood of healthy donors. The cells were resus-
pended in medium (RPMI 1640) at 5  106 cells/ml. For stimula-
tion 200 ll MNC (1  106 cells) were transferred into each well of
a 96-well culture plate. LPS Ra and b2GPI mixtures were preincu-
bated for 30 min at 37 C and added to the cultures at 20 ll per
well. The cultures were incubated for 4 h at 37 C under 5% CO2.
After centrifugation of the culture plates for 10 min at 400g super-
natants were collected and stored at 20 C. TNFa concentrations
were quantiﬁed by a sandwich ELISA using a monoclonal antibody
against TNF (clone 6b from Intex AG, Switzerland).
2.7. X-ray scattering
The aggregate structures of LPS Ra were determined in the
absence and presence of b2GPI using small-angle X-ray scattering
(SAXS). SAXS measurements were performed at the European
Molecular Biology Laboratory (EMBL) outstation at the Hamburg
synchrotron radiation facility HASYLAB using the double-focusing
monochromator-mirror camera X33. Scattering patterns in the
range of the scattering vector 0.01 < s < 0.1 nm1 (s = 2sinh/k, 2h
scattering angle and k the wavelength = 0.15 nm) were recorded
at 20, 40, 60, and 80 C with exposure times of 1 min using an
image plate detector with online readout (MAR345, MarResearch,
Norderstedt/Germany) [12]. The s-axis was calibrated with Ag-
Behenate with a periodicity of 5.84 nm. The scattering patterns
were evaluated as described previously [13] assigning the spacing
ratios of the main scattering maxima to deﬁned three-dimensional
Table 1
Limulus assay of pure b2GPI. In the LAL assay a concentration of 1 ng/ml LPS
corresponds to 10–15 EU/ml. From these data, a medium LPS content of 2 EU/lg can
be estimated.
c(b2GPI)
[lg/ml]
Dilution LAL result
(diluted)
[EU/ml]
LAL result
(undiluted)
[EU/ml]
App. LPS-content
[EU/lg]
800 1 1863.3 1863.3 2.3
80 10 152.99 1529.9 1.9
8 100 14.641 1466.41 1.8
Fig. 1. Secretion of tumor-necrosis-factora from human mononuclear cells induced
by lipopolysaccharide LPS Ra, and LPS:b2GPI mixtures. The error bar results from
the determination of TNFa in an ELISA in duplicate.
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the present study.
2.8. Fourier-transform infrared spectroscopy (FTIR)
FTIR was used to determine (a) the gel to liquid crystalline
phase transition of the hydrocarbon chains of LPS by evaluating
the peak position of the symmetric stretching vibration ms(CH2)
in the wavenumber range 2850–2853 cm1 and (b) the secondary
structure of the protein in the range of the amide I vibration in the
wavenumber range 1700–1600 cm1 [14,15]. The infrared spectro-
scopic measurements were performed on an IFS-55 spectrometer
(Bruker). LPS and LPS:b2GPI samples dispersed in 20 mM Hepes
buffer, pH 7.0 were placed in a CaF2 cuvette between two
12.5 lm teﬂon spacers. For the determination of the phase behav-
ior temperature-scans were performed automatically between 10
and 70 C with a heating-rate of 0.6 C/min. Every 3 C, 50 interfer-
ograms were accumulated, apodized, Fourier transformed and con-
verted to absorbance spectra. For the determination of the
secondary structures an attenuated total reﬂection unit was used
whereupon the protein and protein:LPS mixtures were spread
under evaporation of the excess water in a stream of nitrogen
and measuring the samples at the temperature of the instrument
(30 C).
2.9. Isothermal titration calorimetry (ITC)
Microcalorimetric measurements of the binding of b2GPI to LPS
Ra were performed on an MCS isothermal titration calorimeter
(Microcal Inc.) at 37 C as described previously [13]. LPS Ra
(0.05 mM) was dispensed into the microcalorimetric cell (volume
1.3 ml) and the protein solution (1 mM) was ﬁlled into the syringe
compartment (volume 100 ll). After temperature equilibration
b2GPI was titrated every 5 min in 3 ll portions into the LPS-con-
taining cell under constant stirring and the heat of reaction was
plotted versus time.
2.10. Fluorescence resonance energy transfer spectroscopy (FRET)
The ability of b2GPI to bind to and intercalate into phospholipid
liposomes or into LPS R60 aggregates was investigated by FRET as
described earlier [13]. Brieﬂy, phospholipid liposomes from
phosphatidylserine (PS), phosphatidylcholine (PC) or LPS R60 were
doubly labeled with the ﬂuorescent phospholipid dyes N-(7-nitro-
benz-2-oxa-1,3-diazol-4yl)-phosphatidyl ethanolamine (NBD-PE)
and N-(lissamine rhodamine B sulfonyl)-phosphatidylethanol-
amine (Rh-PE) (Molecular Probes). Intercalation of unlabeled mol-
ecules into the doubly labeled liposomes leads to probe dilution
and thereby to a lower FRET efﬁciency. Thereby the emission
intensity of the donor ID increases and that of the acceptor IA
decreases (for clarity, only the quotient of the donor and acceptor
emission intensity is shown here).
In all experiments 100 ll of 100 lM b2GPI were added to
doubly labeled PC, PS or LPS R60 (900 ll of 10 lM) at 50 s after
equilibration. NBD-PE was excited at 470 nm and the donor and
acceptor ﬂuorescence intensities were monitored at 531 and
593 nm respectively and the ﬂuorescence signal ID/IA was recorded
for further 250 s.
2.11. Determination of endotoxin activity by the chromogenic Limulus
test
To test a possible contamination of b2GPI with endotoxins the
LPS content was determined by a quantitative kinetic assay based
on the reactivity of Gram-negative endotoxin with Limulus
amebocyte lysate (LAL) at 37 C, using test kits of LAL CoamaticChromo-LAL K (Chromogenix, Haemochrom). The standard endo-
toxin used in this test was from Escherichia coli (O55:B5) and 10–
15 endotoxin units (EU)/ml correspond to 1 ng/ml. In this assay
saturation occurs at 50 EU/ml and the resolution limit is 0.05 EU/
ml (maximum value for ultrapure water, Aqua B. Braun).
3. Results
3.1. Purity of b2GPI
Despite the extraction and puriﬁcation procedure leading to a
single band in SDS-PAGE as described above contamination by
LPS cannot be excluded. Therefore endotoxin was determined in
the Limulus amebocyte lysate (LAL) assay and the results are
shown in Table 1. Clearly the protein is not free of LPS. From the
data of Table 1 an endotoxin concentration of 2 EU/lg can be
estimated which corresponds to approximately 150–250 pg LPS
per lg protein.
3.2. Stimulation of mononuclear cells
Serum proteins such as b2GPI are important LPS binding pro-
teins. Therefore the ability of b2GPI to inﬂuence the inﬂammation
induction by LPSwas investigated by stimulatingmononuclear cells
(MNC) with LPS at different concentrations (100 and 10 ng/ml) in
the absence and presence of varying concentrations of b2GPI
([LPS]:[b2GPI] 1:1, 1:10, 1:100, and 1:1000 weight%). The addition
of the protein to LPS at a ratio of 1:1 and 1:10 respectively inﬂu-
enced the LPS-induced cytokine (TNFa) secretion only marginally
(data not shown). At ratios of 1:100 and 1:1000 however a clear
Fig. 2. (A) Trp-ﬂuorescence emission spectra of b2GPI/LPS at a protein concentration of 1.1 lM and in the presence of increasing concentrations of LPS varying from 0 to
40 mol LPS/mol protein. Excitation wavelength was 292 nm. The results are presented in a mesh plot. (B) Changes in the emission maximum of Trp-ﬂuorescence of b2GPI
(1.1 lM) in the presence of lipid vesicles as a function of lipid concentration for LPS (d) and egg-PC (s).
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centrations in the range 2000–1750 pg/ml for pure LPS are signiﬁ-
cantly reduced at [LPS]:[b2GPI] 1:100. Interestingly there is no
further decrease at the highest concentration. In contrary, at
[LPS]:[b2GPI] 1:1000 a highly signiﬁcant increase of TNFa secretion
can be observed. The bar at the right hand side in Fig. 1 shows that
the protein itself seems to be an activator ofMNC. This activity how-
ever could be explained at least partially by the presence of LPS inas-
much as 10 lg/ml b2GPI were contaminated by 2 ng/ml LPS.
3.3. Interaction of b2GPI with LPS-aggregates assessed by Intrinsic
Trp-ﬂuorescence
Interaction of b2GPI with LPS was monitored by measuring
alterations in the ﬂuorescence spectra of tryptophan (Trp), whichoccur due to changes in the microenvironment of Trp-residues.
As shown in our previous paper on the binding behavior of b2GPI
to negatively charged cardiolipin vesicles [5], the Trp-emission
spectrum of b2GPI is rather broad with a maximum (kmax) at about
350 nm. This feature arises by reason of different microenviron-
ments of the ﬁve Trp-residues in b2GPI. Four Trp-residues located
in domain 1–4 are embedded in the interior hardly accessible to
water whereas Trp316 located in domain V is surface exposed
[3]. Despite its apolar nature Trp316 is positioned in a hydrophobic
loop which is surface exposed and was found to be essential for the
lipid-binding capacity of b2GPI, as a single point mutation of this
amino acid completely abrogates lipid binding [16,17]. Thus one
can assume that upon lipid association Trp316 becomes located
in a more hydrophobic lipid environment seen as a blue shift in
the ﬂuorescence emission spectra. Indeed a signiﬁcant blue shift
436 A. Gries et al. / FEBS Open Bio 4 (2014) 432–440from 350 nm to 336 nm was observed when cardiolipin vesicles
were added to a solution of b2GPI. The magnitude of the blue shift
was dependent on the molar ratio of lipid-to-protein being con-
stant above a molar ratio of 20 mol lipid per mol protein [5].
Here we have performed an analogous experiment applying
increasing LPS concentrations between 0 and 45 lM correspond-
ing to molar ratios up to 40 mol LPS/mol b2GPI. Depending on the
concentration of LPS a blue shift from 350 nm to 339 nm was
observed which in contrast to cardiolipin increases linearly up
to 5 lM LPS and remains unchanged above a molar ratio of about
10 (Fig. 2A and B). As b2GPI lacks the ability to bind to
zwitterionic choline headgroups [5,18], the ﬂuorescence emission
maximum observed for egg-PC at 350 nm remained unchanged
(Fig. 2B).
Fig. 3 shows the Stern–Vollmer plots for the quenching of the
intrinsic Trp ﬂuorescence by acrylamide. We observed a non-linear
biphasic characteristic of the quenching curves with an upward
curvature indicative for simultaneous static and dynamic quench-
ing. The effective quenching constants were determined from the
exponential ﬁt as Ksv = 4.5 M1 and 3.2 M1 for b2GPI and b2GPI/
LPS, respectively. The lower quenching rate for b2GPI/LPS indicates
a lower accessibility of Trp-residues to polar quencher in presence
of LPS however the effect is much less pronounced as reported for
cardiolipin [5].
3.4. Gel to liquid crystalline phase transition of the acyl chains of LPS
The gel (b) to liquid crystalline (a) phase transition of LPS
ranges from 30 to 35 C for enterobacterial LPS. Binding to serum
proteins may play a role in modulating immune responses to LPS.
In Fig. 4, in FTIR experiments as sensitive indicator of the phases
the peak position of the symmetric stretching vibration at
2850–2853 cm1 is plotted for pure LPS as well as in the presence
of b2GPI at a ratio of [LPS]:[b2GPI] 1:1 weight%. For LPS alone the
wavenumber values changed from 2850.5 to 2852.5–2853.0 cm1
indicating a midpoint of the transition at 32.4 C which consider-
ably increased to a value of 36.3 C in the presence of [LPS]:[b2-
GPI] 1:1 weight%. At the same time, at all temperatures the
wavenumber values are lower for the sample with protein. Both
effects shift in Tm to higher values as well as decrease in wave-
numbers are characteristic for a rigidiﬁcation of the entire LPS
aggregate.Fig. 3. Quenching of the intrinsic Trp ﬂuorescence of b2GPI by acrylamide. The protein
0.45 M. The Stern–Volmer plot is shown for b2GPI in the absence (N) and in the presenc3.5. Secondary structure of b2GPI
The secondary structures of proteins such as a-helical and
b-sheets and their changes due to interaction with LPS may be of
relevance for an understanding of the mode of action. FTIR allows
an analysis of the secondary structures by evaluating the amide I
vibration in the spectral range of 1700–1600 cm1. The main sec-
ondary structural elements a-helix, b-sheets, and random coils
have maxima at 1650–1657, 1625–1640, and 1645–1660 cm1,
respectively. A particular helical substructure, 310 helices, has
bands around 1637–1643 cm1.
In Fig. 5, data are presented for pure b2GPI and in the presence
of LPS ([LPS]:[b2GPI] 10:1). The pure protein exhibits a main vibra-
tional maximum at 1640.7 cm1, which is shifted to a value of
1648.4 cm1 in the presence of LPS. The position of the former
band may indicate a mixture of a b-sheet and a 310 helical struc-
ture. In the presence of LPS the signiﬁcant shift to higher wave-
numbers is indicative for a transformation, at least partially, into
a random coil organization. Since the assignment to the different
secondary structures may be difﬁcult due to the superposition of
the single band components we have also applied resolution-
enhancing techniques such as Fourier self-deconvolution (FSD)
and second derivatives of the spectra, but these analyzes did not
provide any extra support for an increase in random structure.
3.6. Three-dimensional aggregate structure of LPS
The supramolecular aggregate structure of LPS has been shown
to represent an important determinant for its ability to be biolog-
ically active i.e. by inducing the cytokine production in human
MNC. Changes of the aggregate structure due to protein binding
may strongly inﬂuence the capability of LPS to induce cytokines.
The determination of the aggregate structure can be performed
by SAXS which shows characteristic scattering patterns depending
on the kind of aggregates. For pure LPS the scattering patterns
exhibit broad intensity distributions between s values of 0.15–
0.35 nm1 indicating the existence of LPS bilayer systems (form
factor), which do not show a particular aggregation behavior (no
structure factor), in accordance to numerous data published earlier
[19].
In the presence of the protein ([LPS]:[b2GPI] 1:4) the scattering
patterns in the range of 20–80 C (Fig. 6) exhibit sharp reﬂectionsconcentration was set to 1.1 lM. The acrylamide concentration was increased to
e of 20 mol LPS/mol protein (d).
Fig. 4. Gel to liquid crystalline phase transition of the acyl chains of LPS Ra in the
absence and presence of b2GPI at [LPS]:[b2GPI] 10:1 weight%. Shown is the peak
position of the symmetric stretching vibration of the methylene groups ms(CH2)
versus temperature. In the gel phase, the position lies around 2850.5, in the liquid
crystalline phase at 2852.5–2853 cm1.
Fig. 5. Infrared vibrational spectra in the range of the amide I band (predominantly
C@O stretching vibration). The position of the peak maxima can be assigned to
different secondary structures due to different water binding, i.e., a-helix between
1650 and 1655 cm1, b-sheets between 1625 and 1640 cm1, and a particular
helical structure 310-helix between 1637 and 1643 cm1.
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also with the third order reﬂection at dl/3. This behavior can be
interpreted as occurrence of a multilamellar LPS aggregate due to
protein binding with a lamellar periodicity of 9.12–8.77 nm gener-
ated i.e. by distances between neighboring bilayer planes. However
from the sharpness of the single reﬂections it can be deduced that
the multilamellarization is only weakly expressed.
3.7. Thermodynamics of binding of b2GPI to lipopolysaccharide
Isothermal titration calorimetry (ITC) is an important technique
to study the thermodynamics of molecule interactions. In this way
characteristics of binding (endotherm, exotherm), the binding stoi-
chiometry and saturation can be analyzed.Data presented in Fig. 7 indicate an exclusively exothermic pro-
cess, which however does not show a sigmoidal saturation proﬁle
as normally observed in this type of measurement. A sigmoidal
response is not necessarily to be expected in the case of speciﬁc
interactions, in particular for binding proteins such as lactoferrin.
It was not possible over the range of [protein]:[LPS] ratios used
here to evaluate binding constants. Furthermore, the observed
small enthalpy changes in the range 8 to 2 kJ/mol indicate only
a weak binding of the protein to LPS.
3.8. Intercalation of b2GPI into phospholipids or LPS
FRET was applied to study a possible intercalation of b2GPI into
phospholipid liposomes made from PC or PS or into LPS aggregates.
As shown in Fig. 8A–C there is only a very weak interaction of
b2GPI with PC (Fig. 8A) leading to an insigniﬁcant change of the
FRET signal of 0.02. For the interaction of b2GPI with the negatively
charged phospholipid PS there is a much higher change of the FRET
signal of nearly 0.2 (Fig. 8B). Despite the highly negative head
group charge of LPS the interaction with b2GPI leads to an increase
of the FRET of only 0.05 (Fig. 8C).
4. Discussion
We have performed a biophysical analysis of the abundant
serum protein b2GPI with bacterial lipopolysaccharides and in
some cases also with phospholipids to understand the still insufﬁ-
ciently deﬁned role of b2GPI. We have found that b2GPI provokes
an increase in the phase transition temperature of LPS (Fig. 4).
Additionally a change of the aggregate structure of LPS with a mod-
erate tendency to aggregate into a multilamellar phase was
observed (Fig. 6). At the same time the interaction indicates a
clearly exothermic process (Fig. 7) which, however, shows no sat-
uration characteristics. This is in accordance with the rather weak
interaction in the FRET experiment (Fig. 8C) being lower than that
with the negatively charged PS (Fig. 8A), despite the fact that the
surface charge density of PS is lower than that of LPS. Concomi-
tantly to these physical data the biological experiment exhibits a
moderate decrease of the LPS-induced stimulation of human
mononuclear cells (Fig. 1) in a concentration range ([LPS]:[b2GPI]
1:1–1:100) in which the endotoxin contaminant within the b2GPI
does not yet play a role.
The experimental data of the secondary structures of the pro-
tein (Fig. 5) are indicative of a slight transformation of the b-sheet
and a 310 helical structure of the protein into – as one possible
interpretation – a random coil conformation. Literature data of sec-
ondary structures of b2GPI have been published by Paolorossi and
Montich [20] and Borchman et al. [21]. The former group found –
among others – a temperature-dependent distribution of b-sheets
(bands at 1631–1636 cm1) and a-helical structures with the for-
mer structures dominant at 25 C and the latter at 50 C. In the
presence of negatively charged phosphatidylglycerols (POPG,
DMPG, DPPG), the main components at 1631–1633 cm1 remained
corresponding to b-sheets but may be inﬂuenced by the addition of
NaCl leading partially to more a-helical structures. The data of Bor-
chman et al. [21] show signiﬁcant variations already for different
preparations of the protein with 27 and 39% a-helix and b-sheets
for one and 36 and 53% respectively for the other. Also the turns
vary considerably while no random coil structures were observed.
In the presence of phosphatidylcholine the structural units corre-
sponding to turns nearly disappeared whereas the addition of the
negatively charged cardiolipin led to a signiﬁcant increase of ran-
dom coil structures. This phenomenon was also observed in this
work after addition of LPS. Summarizing the different data and
interpretations in the literature and observed in our experiments
Fig. 6. Small-angle X-ray scattering (SAXS) of a [LPS]:[b2GPI] 1:4 weight% dispersion at 20–80 C. The logarithm of the scattering intensity log I is plotted versus the scattering
vector s (=1/d, d = spacings of the reﬂections).
Fig. 7. Isothermal titration calorimetric experiments of LPS protein mixtures. To a
LPS dispersion (1 mM), b2GPI (2 mg/ml) is titrated in 3 ll portions. Measurements
were done at 37 C. Exothermic processes lead to negative, endothermic processes
to positive enthalpy changes DHc.
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plex behavior of b2GPI alone and in the presence of different lipids.
Therefore further detailed analyzes of the interaction of the protein
with the most important lipid systems deserve closer attention.
Agar and co-workers published data from which they deduced
that b2GPI belongs to the class of defensive proteins by scavengingLPS [7]. These data result among others from the inhibition of the
LPS-induced production of tissue factor and interleukin-6 in mono-
cytes. In contrast to this hypothesis our data do not favor an impor-
tant role of b2GPI as defense structure. Biophysical data of other
defense structures such as polymyxin B [22], high-density lipopro-
tein [23], lactoferrin [24] and various antimicrobial peptides [25]
indicate a much higher change of LPS membrane ﬂuidity leading
in most cases to complete ﬂuidization, considerably higher multil-
amellarization of the LPS aggregates and a much higher exothermic
reaction in the ITC experiments with starting values of 80 kJ/mol
and with saturation characteristics. Furthermore the decrease of
the LPS-induced immunostimulatory activity elicited by the pro-
tein in the range [LPS]:[b2GPI] 1:1–1:100 weight% shown in Fig. 1
is much lower than for the defense proteins and peptides described
above [18–21].
The weak and non-saturable binding of b2GPI to LPS – resem-
bling a catalysis-like process, but not necessarily being catalytic
– could be a signal of an immune modulating function of the pro-
tein. This view is supported by FRET data (Fig. 8B) and is in accor-
dance with the strong interaction of b2GPI with phosphatidylserine
(PS) as reported earlier [18]. In this work a direct interaction of the
positively charged lysine-rich region of b2GPI with the PS head
group was suggested. As also presented in our work PS is an impor-
tant phospholipid compound in the context of apoptotic processes.
Thereby PS is exported from the inner monolayer of immune cells
to its outer side thereby being directly accessible to the action of
b2GPI. In this sense we would agree with the statement of Agar
et al. [7] that b2GPI could play a role as component of innate immu-
nity. Regarding their data of cytokine inhibition however, which is
only moderate even at rather high excess of b2GPI with respect to
LPS we would not support the view that b2GPI has a signiﬁcant role
for LPS neutralization and clearance. The interpretation of an
immune modulating property of b2GPI seems also to be in accor-
dance with data of Ninivaggi et al. [26] who found that b2GPI incu-
bated with phospholipids inhibited the generation of thrombin.
Laplante et al. [6] also investigated the interaction of b2GPI with
LPS. They reported that b2GPI interacts speciﬁcally with LPS and
that this interaction is responsible for apparent TLR4 activation
Fig. 8. Förster resonance energy transfer spectroscopy (FRET) of mixtures from doubly labeled 0.01 mM phosphatidylcholine (A), phosphatidylserine (B) and LPS Ra (C) with
b2GPI (10 lM) added after 50 s. The FRET signal ID/IA is a sensitive measure of incorporation of the protein into the lipids.
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speciﬁc (see above) and (ii) there is a signiﬁcant interaction of
b2GPI with TLR4. Laplante et al. were unable to prove the latter
interaction because they found no immune stimulatory action of
b2GPI in cases when the contaminating LPS was removed by puri-
ﬁcation or by polymyxin B. Thus, their statement that ‘both LPS and
TLR4 are required for b2GPI to bind to and activate macrophages’
remains not fully supported.
Further experiments seem to be necessary to elucidate the
interaction of b2GPI with LPS and other negatively charged lipids
from different membranes. Particularly atomic force microscopy
should be applied to give a view on the immune cell’s membrane
to explain the direct interaction of b2GPI and b2GPI:LPS mixtures
with the membrane and its components, in particular with
phosphatidylserine.
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